Biocartis US (@BiocartisUS) / X

Biocartis

Biocartis

Biocartis (@Biocartis_) / X

Biocartis (@Biocartis_) / X

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access

Biocartis

Biocartis launched its fully automated Idylla™ SARS-CoV-2/Flu/RSV Panel. The test is intended to detect SARS-CoV-2, Flu A/B & RSV and runs on our rapid, By Biocartis

BioXclude Membrane - Whitecap Dental Solution

Biocartis

About us Biocartis

Biocartis

Renate Degrave (@RenateDegrave) / X

Biocartis US on X: The #Idylla™ #molecular testing workflow is a breeze - don't wait to bring it in-house as a perfect complement to your #NGS workflow, when rapid results are of